Skip to main content
Clinical Trials/CTRI/2020/05/025358
CTRI/2020/05/025358CompletedPhase 2

Comparative pharmaceutico-analytical study of two types of kanta loha bhasmas and their clinical efficacy in the management of madhumeha(type 2 diabetes) - type 2 diabetes

Institute for Post Graduate Teaching and Research in Ayurveda0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • .Known patient of type 2 diabetes and also preliminary diagnosed patients
  • .patients having fasting blood sugar >126mg/dl and/or PPBS >200mg/dl or elevated HbA1C

Exclusion Criteria

  • .Patients of any other severe illnes
  • .Patients having diabetic non healing wound,systemic infection,malignant and accelarated hypertensive
  • .Patients having severe anaemia Hb% <7 gm%
  • .Patients with diabetic ketoacidosis,end stage renal disease

Investigators

Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda

Similar Trials